In vivo and in vitro evidence showed that SLNCR1 was closely related to breast cancer, and YY1 directly bound to the promoter region of SLNCR1 and enhanced the expression level of SLNCR1, leading to the proliferation of breast cancer cells and tumor growth.8 Here, YY1 is linked to breast carcinoma.